JIA JIE BIOMEDICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21 TWD | +0.48% |
|
-15.32% | +22.09% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 318M 9.83M 13.41M | Sales 2023 | 333M 10.3M 14.04M | Capitalization | 1.53B 47.34M 64.55M |
|---|---|---|---|---|---|
| Net income 2022 | -5M -155K -211K | Net income 2023 | 144M 4.46M 6.08M | EV / Sales 2022 | 3.34 x |
| Net cash position 2022 | 245M 7.58M 10.34M | Net cash position 2023 | 140M 4.34M 5.92M | EV / Sales 2023 | 4.18 x |
| P/E ratio 2022 |
-239
x | P/E ratio 2023 |
10.6
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
2.91% | Free-Float | 55.92% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.48% | ||
| 1 week | -15.32% | ||
| Current month | -17.16% | ||
| 1 month | -19.69% | ||
| 3 months | +4.48% | ||
| 6 months | +52.73% | ||
| Current year | +22.09% |
1 week
20.10
23.40
1 month
20.1026.15
Current year
16.3527.80
1 year
13.0027.80
3 years
12.3527.80
5 years
10.2027.80
10 years
10.2032.44
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Chuan Tseng
CEO | Chief Executive Officer | - | - |
Ching Hung Lin
DFI | Director of Finance/CFO | - | 13-07-13 |
Yi Chien Chung
PRN | Corporate Officer/Principal | - | 16-03-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01-05-09 | |
Yi Chien Chung
PRN | Corporate Officer/Principal | - | 16-03-26 |
Ching Hung Lin
DFI | Director of Finance/CFO | - | 13-07-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 21 | +0.48% | 344 742 |
| 24-05-13 | 20.9 | -3.24% | 1,217,916 |
| 24-05-10 | 21.6 | +0.47% | 633,766 |
| 24-05-09 | 21.5 | -3.37% | 1,140,066 |
| 24-05-08 | 22.25 | -9.55% | 3,470,204 |
End-of-day quote Taipei Exchange, May 13, 2024
More quotes
Jia Jie Biomedical Co Ltd is a Taiwan-based company mainly engaged in the processing, production and distribution of turtles and turtle processed products. The Company operates through two business segments. Taiwan Operation segment is engaged in the production and sale of health foods. China Mainland Operation segment is engaged in the production of water purification equipment and related parts. Products are include nutrition and health care series, health water series, home supplies series. Products are mainly sold to Taiwan and mainland China.
Sector
Food Processing
| 1st Jan change | Capi. | |
|---|---|---|
| +22.09% | 63.64M | |
| +20.87% | 8.44B | |
| +7.54% | 7.78B | |
| +12.95% | 6.77B | |
| -4.42% | 3.81B | |
| -5.81% | 3.71B | |
| +2.08% | 1.4B | |
| -26.15% | 1.09B | |
| +24.00% | 1.03B | |
| -11.23% | 901M |
- Stock Market
- Equities
- 4109 Stock